1Deer, T. R., Raso, L.J. Spinal cord stimulation for refractory angina pectoris and peripheral vascular dlsease[J] .Pain Physician,2006,9:347.
2Garcia, L.A. Epidemiology and pathophysiology of lower extremity peripheral arterial disease[J].J Endovasc Ther,2006,13(2) :3.
3Chochola, M., Linhart, A. Epidemiology of ischemic diseases of the lower extremities[J]. Cas Lek Cesk,2006,145(3) :68.
4Caraeron, T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20- year literature review[J] .J Neurosurg,2004, 100:254.
5Tanaka, S., Barron, K.W., Chandler, M.J., Linderoth, B., Foreman, R.D.b. Local cooling alters neural mechanisms producing changes in peripheral blood flow by spinal cord stimulation[J]. Auton Neuroacl, 2003,28:117.
6Tanaka, S., Komori, N., Barton, K.W., Chandler, M.J., Linderoth, B., Foreman, R.D. Mechanisms of sustained cutaneous vasodilation induced by spinal cord stimulation[J]. Auton Neurosci,2004,114: 55.
7Tanaka, S., Barron, K.W., Chandler, M.J., Linderoth, B., Foreman, R.D. Role of primary afferents in spinal cord stimulation- induced vasodilation: characterization of fiber types [ J ]. Brain Res, 2003, 959: 191.
8Brain, S.D., Grant, A.D. Vascular actions of calcitonin generelated peptide and adrenomedullin[ J]. Physiol Rev,2004,84:903.
9Chiba, T., Yamaguchi, A., Yamatani, T., Nakamura, A., Morishita, T., Inui, T., Fukase, M., Noda, T., Fujita, T. Calcitanin gene-related peptide receptor antagonist human CGRP- (8 - 37) [J] .Am J Physiol, 1989,256(E) :331
10Wu, M., Komori, N., Qin, C., Fader, J.P., Linderoth, B., Foreman, R.D. Extmcellular signal - regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS) - induced vasodilation[J] .FASEB J,2006,20: A1402.
